Stay informed with the latest litigation news. Explore now

IP Verse

Treatment Of Retinal Degeneration Using Gene Therapy - EP3110433B2

EP3110433

THE UNIVERSITY OF MANCHESTER
Application Number
EP15707722A
Filing Date
Feb 24, 2015
Status
Patent Maintained As Amended
Jan 20, 2023
Grant Date
Feb 22, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2687223B2
EP2836223B2
EP3510402B1

Bibliography

The patent EP3110433B2 was granted to The University OF Manchester on Feb 22, 2023 following the initial filing on Feb 24, 2015 under the application number EP15707722A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRATAGEMApr 17, 2020WITHDRAWN
KELTIEApr 9, 2020WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents